231 related articles for article (PubMed ID: 10097145)
21. The immunotoxin activity of exotoxin A is sensitive to domain modifications.
Amiri Tehranizadeh Z; Sankian M; Fazly Bazzaz BS; Chamani J; Mehri S; Baratian A; Saberi MR
Int J Biol Macromol; 2019 Aug; 134():1120-1131. PubMed ID: 31129209
[TBL] [Abstract][Full Text] [Related]
22. Immunotoxins made with a recombinant form of Pseudomonas exotoxin A that do not require proteolysis for activity.
Theuer CP; Kreitman RJ; FitzGerald DJ; Pastan I
Cancer Res; 1993 Jan; 53(2):340-7. PubMed ID: 8417828
[TBL] [Abstract][Full Text] [Related]
23. Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.
Vallera DA; Carroll SF; Snover DC; Carlson GJ; Blazar BR
Blood; 1991 Jan; 77(1):182-94. PubMed ID: 1984794
[TBL] [Abstract][Full Text] [Related]
24. Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice.
Benhar I; Pastan I
Clin Cancer Res; 1995 Sep; 1(9):1023-9. PubMed ID: 9816075
[TBL] [Abstract][Full Text] [Related]
25. A variant of exotoxin A that forms potent and specific chemically conjugated immunotoxins.
Chaudry GJ; Fulton RJ; Draper RK
J Biol Chem; 1993 May; 268(13):9437-41. PubMed ID: 8486636
[TBL] [Abstract][Full Text] [Related]
26. B3(Fab)-PE38M: a recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3.
Choe M; Webber KO; Pastan I
Cancer Res; 1994 Jul; 54(13):3460-7. PubMed ID: 8012967
[TBL] [Abstract][Full Text] [Related]
27. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
[TBL] [Abstract][Full Text] [Related]
28. Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A.
Mazor R; Vassall AN; Eberle JA; Beers R; Weldon JE; Venzon DJ; Tsang KY; Benhar I; Pastan I
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):E3597-603. PubMed ID: 23213206
[TBL] [Abstract][Full Text] [Related]
29. Recombinant toxins that bind to the urokinase receptor are cytotoxic without requiring binding to the alpha(2)-macroglobulin receptor.
Rajagopal V; Kreitman RJ
J Biol Chem; 2000 Mar; 275(11):7566-73. PubMed ID: 10713063
[TBL] [Abstract][Full Text] [Related]
30. Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin.
Kreitman RJ; Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
Bioconjug Chem; 1992; 3(1):63-8. PubMed ID: 1616951
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y
J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313
[TBL] [Abstract][Full Text] [Related]
32. Role of caspases in immunotoxin-induced apoptosis of cancer cells.
Keppler-Hafkemeyer A; Brinkmann U; Pastan I
Biochemistry; 1998 Dec; 37(48):16934-42. PubMed ID: 9836586
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of the activity of immunotoxins made with either ricin A chain or Pseudomonas exotoxin in human ovarian and epidermoid carcinoma cell lines.
Pirker R; FitzGerald DJ; Willingham MC; Pastan I
Cancer Res; 1988 Jul; 48(14):3919-23. PubMed ID: 3260128
[TBL] [Abstract][Full Text] [Related]
34. Why toxins!
Fitzgerald D
Semin Cancer Biol; 1996 Apr; 7(2):87-95. PubMed ID: 8740564
[TBL] [Abstract][Full Text] [Related]
35. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
[TBL] [Abstract][Full Text] [Related]
36. In vitro studies of ricin A-chain-induced vascular leak syndrome.
Lindstrom AL; Pennell CA
Methods Mol Biol; 2001; 166():125-35. PubMed ID: 11217363
[No Abstract] [Full Text] [Related]
37. Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation.
Kuan CT; Pastan I
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):974-8. PubMed ID: 8577771
[TBL] [Abstract][Full Text] [Related]
38. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells.
Du X; Ho M; Pastan I
J Immunother; 2007 Sep; 30(6):607-13. PubMed ID: 17667524
[TBL] [Abstract][Full Text] [Related]
39. Chemical construction of immunotoxins.
Ghetie V; Vitetta ES
Mol Biotechnol; 2001 Jul; 18(3):251-68. PubMed ID: 11503519
[TBL] [Abstract][Full Text] [Related]
40. An early step in Pseudomonas exotoxin action is removal of the terminal lysine residue, which allows binding to the KDEL receptor.
Hessler JL; Kreitman RJ
Biochemistry; 1997 Nov; 36(47):14577-82. PubMed ID: 9398176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
